- Home
- FLGT
as 12-20-2024 4:00pm EST
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.
| Founded: | 2011 | Country: | United States |
| Employees: | N/A | City: | EL MONTE |
| Market Cap: | 683.5M | IPO Year: | 2016 |
| Target Price: | $22.00 | AVG Volume (30 days): | 298.0K |
| Analyst Decision: | Hold | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -5.50 | EPS Growth: | N/A |
| 52 Week Low/High: | $16.56 - $30.68 | Next Earning Date: | 11-08-2024 |
| Revenue: | $277,761,000 | Revenue Growth: | -3.02% |
| Revenue Growth (this year): | -0.06% | Revenue Growth (next year): | 16.00% |
Stock Insider Trading Activity of Fulgent Genetics Inc. (FLGT)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Gao Hanlin | FLGT | Chief Scientific Officer | Dec 3 '24 | Sell | $19.50 | 1,373 | $26,773.36 | 919,469 | |
| Xie Jian | FLGT | President and COO | Dec 3 '24 | Sell | $19.50 | 1,455 | $28,372.35 | 334,681 | |
| Hsieh Ming | FLGT | Chief Executive Officer | Nov 25 '24 | Sell | $18.26 | 2,227 | $40,663.46 | 703,711 | |
| Gao Hanlin | FLGT | Chief Scientific Officer | Nov 25 '24 | Sell | $18.26 | 497 | $9,074.87 | 919,469 | |
| Xie Jian | FLGT | President and COO | Nov 25 '24 | Sell | $18.26 | 689 | $12,580.66 | 334,681 |
Latest Fulgent Genetics Inc. News
FLGT Breaking Stock News: Dive into FLGT Ticker-Specific Updates for Smart Investing
Simply Wall St.
16 hours ago
With 54% ownership, Fulgent Genetics, Inc. (NASDAQ:FLGT) boasts of strong institutional backing
Argus Research
4 days ago
HXL: Lowering target price to $20.00
Argus Research
11 days ago
FLGT: What does Argus have to say about FLGT?
Zacks
13 days ago
Wall Street Analysts Predict a 31.06% Upside in Fulgent Genetics (FLGT): Here's What You Should Know
Argus Research
18 days ago
FLGT: Raising target price to $21.00
Argus Research
25 days ago
FLGT: Raising target price to $19.00
Zacks
a month ago
All You Need to Know About Fulgent Genetics (FLGT) Rating Upgrade to Strong Buy
Insider Monkey
a month ago
Fulgent Genetics, Inc. (FLGT): Among the Best Genomics Stocks to Buy Right Now
Compare FLGT vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "FLGT Fulgent Genetics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.